calendar

4 catalysts · 4 approval

next 91 dayslessmore

MonWedFri

view

sort

type

therapy area

no tagged catalysts yet

Week of Jan 23, 2017

›Jan 24, 2017approval3478d agoQUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: NEXTWAVE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL

›Jan 24, 2017approval3478d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

›Jan 24, 2017approval3478d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

›Jan 24, 2017approval3478d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

$COLL35.39-1.64%

$RDY11.85+0.17%